The benefits of GLP-1 drugs may fade faster than expected when treatment is interrupted. GLP-1 drugs have quickly moved from niche diabetes treatments to some of the most talked-about medications in the country. Drugs such as semaglutide and tirzepatide are now used by about one in eight U.S. adults, not only for blood sugar control […]